Red Light Therapy, Protocols & AI Workflows (w/ John Graham Harper, Lumaflex)

In Episode 12 of Two Tokens Short, Robert De La Rosa and Mitchell Newberger sit down with John Graham Harper, founder of Lumaflex, to unpack how red light therapy (photobiomodulation) is moving from “wellness trend” to clinically-informed recovery—and where AI slots into the next phase.

John traces his path from combat sports injuries and a scary tumor discovery to building an FDA-cleared, portable RLT system used by medical teams, first responders, and pro organizations. We dig into what actually matters—nanometers vs. frequencies, contact protocols vs. distance panels, power density, and why skin contact + 10-minute standardized dosing is core to Lumaflex’s approach.

The convo hits the operational side too: global regulatory (FDA, Health Canada, EU MDR, Middle East, NMPA/China), supply chain (diodes, liquid silicone, ruggedization), and market channels (clinics, teams, military, gyms for brand presence). Then we blueprint AI use-cases: turning 9k+ RLT studies into plain-language protocols in-app, practitioner feedback loops that auto-summarize outcomes, and comms automations that scale launches across new regions—without risking medical claims.

If you care about recovery tech, evidence-based protocols, and using AI to bridge research and real-world outcomes, this one’s a keeper.

✨ Insert Coin, Unlock Conversation.